CGAS and neoplasm: We validated these findings in an independent cohort24, where we likewise observed upregulation of CGAS, TMEM173 and downstream inflammation-related mRNAs, including non-canonical NF-κB targets, in high-risk tumor cells (Supplementary Fig. 10a).